Irritable Bowel Syndrome: More Than Abdominal Pain and Bowel Habit Abnormalities

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 1, 2009, Pages 73-79

  Bond, Brian ^a   Quinlan, Judith ^b   Dukes, George E ^b   Mearin, Fermin ^c   Clouse, Ray E ^d   Alpers, David H ^d  

^a Prism Training Consultancy Ltd   (United Kingdom)

^b GLAXOSMITHKLINE   (United States)

^c CENTRO MÉDICO TEKNON   (Spain)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL DISCOMFORT; ABDOMINAL DISTENSION; ABDOMINAL PAIN; ARTICLE; BURNING SENSATION; CLINICAL ASSESSMENT; CONSTIPATION; DEFECATION HABIT; DIARRHEA; DISEASE SEVERITY; FLATULENCE; HUMAN; IRRITABLE COLON; ITALY; MAJOR CLINICAL STUDY; NATURALISTIC INQUIRY; PROSPECTIVE STUDY; QUESTIONNAIRE; SECONDARY ANALYSIS; STOMACH PAIN; SYMPTOMATOLOGY;

ABDOMINAL PAIN; CONSTIPATION; DIARRHEA; FLATULENCE; HUMANS; IRRITABLE BOWEL SYNDROME; PRINCIPAL COMPONENT ANALYSIS; SEVERITY OF ILLNESS INDEX;

EID: 58049217027     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2008.08.011     Document Type: Article

References (24)

1. Manning A.P., Thompson W.G., Heaton K.W., et al. Towards a positive diagnosis of the irritable bowel. Br Med J 2 (1978) 653-654
2. Drossman D.A., Richter J.E., and Talley N.J. The functional gastrointestinal disorders: diagnosis, pathophysiology and treatment: a multinational consensus 1st ed (1994), Degnon Associates, McLean, VA
3. Drossman D.A., Corazziari E., and Talley N.J. ROME II. The functional gastrointestinal disorders. Diagnosis, pathophysiology and treatment: a multinational consensus. 2nd ed. (2000), Degnon Associates, McLean, VA
4. Drossman D.A., Corazziari E., and Delvaux M. Rome III. The functional gastrointestinal disorders. 3rd ed. (2006), Degnon Associates, McLean, VA
5. Camilleri M., Northcutt A.R., Kong S., et al. Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomized, placebo-controlled trial. Lancet 355 (2000) 1035-1040
6. Muller-Lissner S.A., Fumagalli I., Bardhan K.D., et al. Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating, and constipation. Aliment Pharmacol Ther 15 (2001) 1655-1666
7. Guilera M., Balboa A., and Mearin F. Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review. Am J Gastroenterol 100 (2005) 1-11
8. Mearin F., Baro E., Roset M., et al. Clinical patterns over time in irritable bowel syndrome: symptom instability and severity variability. Am J Gastroenterol 99 (2003) 113-121
9. Williams R.E., Black C.L., Kim H.-Y., et al. Stability of irritable bowel syndrome using a Rome-II based classification. Aliment Pharmacol Ther 23 (2006) 197-205
10. Walter S.A., Ragnarsson G., and Bodemar G. New criteria for irritable bowel syndrome based on prospective symptom evaluation. Am J Gastroenterol 100 (2005) 2598-2599
11. Tillisch K., Labus J.S., Naliboff B.D., et al. Characterization of alternating bowel habit subtype in patients with irritable bowel syndrome. Am J Gastroenterol 100 (2005) 896-904
12. Bittner A.C., Croffut R.M., and Stranahan M.C. Prescript-assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study. Clin Ther 27 (2005) 755-761
13. Robbins J.M., Kirmayer L.J., and Hemami S. Latent variable models of functional somatic distress. J Nerv Mental Dis 185 (1997) 606-615
14. Nimnuan C., Rabe-Hesketh S., Wessely S., et al. How many functional somatic syndromes?. Psychosom Res 51 (2001) 549-557
15. Camilleri M., Mangel A.W., Fehnel S.E., et al. Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints. Clin Gastroenterol Hepatol 5 (2007) 534-540
16. Lembo A., Ameen V.Z., and Drossman D.A. Irritable bowel syndrome: toward an understanding of severity. Clin Gastroenterol Hepatol 3 (2005) 717-725
17. Chatfield C., and Collins A.J. Introduction to multivariate analysis (1980), Chapman and Hall, London 57-79
18. Owens D.M., Nelson D.K., and Talley N.J. The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann Intern Med 122 (1995) 107-112
19. Jaiwala J., Imperiale T.F., and Kroenke K. Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. Ann Intern Med 133 (2000) 136-147
20. Costanza C.D., Longstreth G.F., and Liu A.L. Chronic abdominal wall pain: clinical features, health care costs, and long-term outcome. Clin Gastroenterol Hepatol 2 (2004) 395-399
21. Whitehead W.E., Palsson O., and Jones K.R. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?. Gastroenterology 122 (2002) 1140-1156
22. North C.S., Downs D., Clouse R.E., et al. The presentation of irritable bowel syndrome in the context of somatization disorder. Clin Gastroenterol Hepatol 2 (2004) 787-795
23. Walker E.A., Gelfand A.N., Gelfand M.D., et al. Psychiatric diagnoses, sexual and physical victimization, and disability in patients with irritable bowel syndrome or inflammatory bowel disease. Psychol Med 25 (1995) 1259-1267
24. Spiegel B.M.R., Gralnek I.M., Bolus R., et al. Clinical determinants of health-related quality of life in patients with irritable bowel syndrome. Arch Intern Med 164 (2004) 1773-1780